Cargando…
Regulation 536/2014 and its beneficial impacts on academic clinical research in Italy. Closing the loop
Regulation (EU) No 536/2014 (Clinical Trial Regulation, CTR) offers two precious tools to academic clinical research in Italy: - The right to transfer not-for-profit clinical trials data and results for registration purposes, and co-sponsorship. - The right to transfer data reduces the time needed t...
Autores principales: | Mancino, Alessandra, Crea, Enrico, Messina, Monica, Ferrante, Marco, Feraco, Maria Valeria, Fazi, Paola, Vignetti, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465308/ https://www.ncbi.nlm.nih.gov/pubmed/36105266 http://dx.doi.org/10.1016/j.conctc.2022.100992 |
Ejemplares similares
-
P495: UNLOCKING THE POTENTIAL OF SYNTHETIC PATIENTS FOR ACCELERATING CLINICAL TRIALS: RESULTS OF THE FIRST GIMEMA EXPERIENCE
por: Piciocchi, Alfonso, et al.
Publicado: (2023) -
Main changes in European Clinical Trials Regulation (No 536/2014)
por: Tenti, E., et al.
Publicado: (2018) -
Transparenz in der klinischen Forschung: Welchen Beitrag leistet die neue EU-Verordnung 536/2014?
por: Strech, Daniel
Publicado: (2022) -
The GIMEMA-ALLIANCE Digital Health Platform for Patients With Hematologic Malignancies in the COVID-19 Pandemic and Postpandemic Era: Protocol for a Multicenter, Prospective, Observational Study
por: Efficace, Fabio, et al.
Publicado: (2021) -
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey
por: Palandri, Francesca, et al.
Publicado: (2020)